The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research Oct 2012
- 5179-87 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1557-3265
10.1158/1078-0432.CCR-12-0726 doi
Algorithms Clinical Trials, Phase I as Topic Data Interpretation, Statistical Dose-Response Relationship, Drug Drug-Related Side Effects and Adverse Reactions Humans Maximum Tolerated Dose Models, Statistical Sample Size